Results For "IDEFIRIX"

1 News Found

Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115M deal

News | May 21, 2026

Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115M deal

SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization

Latest Stories

IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26

Takeda Pharma ordered to pay $2.5 billion in Amitiza case

Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare

Precision oncology must be decentralized to reach every patient: Dr Vidya Veldore, Vice President, Clinical Operations, 4baseCare

Dr Vidya Veldore Vice President, Clinical Operations, 4baseCare

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

Dushyant Sapre Founder and CEO, SwishX

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Duraisamy Rajan Palani Founder and CEO, Archimedis Digital

Packaging